KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Equity Income: 2010-2015

Historic Equity Income for Charles River Laboratories International (CRL) over the last 6 years, with Dec 2015 value amounting to $3.8 million.

  • Charles River Laboratories International's Equity Income fell 86.36% to $442,000 in Q3 2016 from the same period last year, while for Sep 2016 it was $8.7 million, marking a year-over-year increase of 58.05%. This contributed to the annual value of $3.8 million for FY2015, which is 58.90% down from last year.
  • Charles River Laboratories International's Equity Income amounted to $3.8 million in FY2015, which was down 58.90% from $9.3 million recorded in FY2014.
  • In the past 5 years, Charles River Laboratories International's Equity Income ranged from a high of $9.3 million in FY2014 and a low of -$618,000 during FY2012.
  • Over the past 3 years, Charles River Laboratories International's median Equity Income value was $5.9 million (recorded in 2013), while the average stood at $6.3 million.
  • In the last 5 years, Charles River Laboratories International's Equity Income plummeted by 171.12% in 2012 and then surged by 1,054.69% in 2013.
  • Over the past 5 years, Charles River Laboratories International's Equity Income (Yearly) stood at $869,000 in 2011, then plummeted by 171.12% to -$618,000 in 2012, then spiked by 1,054.69% to $5.9 million in 2013, then surged by 57.64% to $9.3 million in 2014, then slumped by 58.90% to $3.8 million in 2015.